Literature DB >> 8225635

Biliary tract infections treated with ciprofloxacin.

G N Karachalios1, G Zografos, V Patrikakos, D Nassopoulou, K Kehagioglou.   

Abstract

Thirty-two patients with severe biliary tract infections (cholecystitis and cholangitis) were treated with ciprofloxacin intravenously followed by oral ciprofloxacin. Complete clinical and bacteriological cure has been observed in 28 out of 32 patients and therapy failure occurred in four patients. Overall, no major adverse effects were encountered. These data suggest that intravenous ciprofloxacin followed by oral administration is an effective and safe agent for the therapy of severe biliary tract infections.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8225635     DOI： 10.1007/bf01728909

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  7 in total

1.  Use of ciprofloxacin in biliary sepsis.

Authors:  C J Chrysanthopoulos; A T Skoutelis; J C Starakis; A Arvaniti; H P Bassaris
Journal:  Infection       Date:  1988 Jul-Aug       Impact factor: 3.553

Review 2.  Aminoglycosides: assessing the potential for nephrotoxicity.

Authors:  S E Wilson
Journal:  Surg Gynecol Obstet       Date:  1990

3.  Antibiotics in infections of the biliary tract.

Authors:  E L Muller; H A Pitt; J E Thompson; J E Doty; L L Mann; B Manchester
Journal:  Surg Gynecol Obstet       Date:  1987-10

4.  Broad spectrum penicillin as an adequate therapy for acute cholangitis.

Authors:  J E Thompson; H A Pitt; J E Doty; J Coleman; C Irving
Journal:  Surg Gynecol Obstet       Date:  1990-10

Review 5.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

6.  Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.

Authors:  T Bergan; S B Thorsteinsson; R Solberg; L Bjornskau; I M Kolstad; S Johnsen
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

7.  Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis.

Authors:  W B Gerecht; N K Henry; W W Hoffman; S M Muller; N F LaRusso; J E Rosenblatt; W R Wilson
Journal:  Arch Intern Med       Date:  1989-06
  7 in total
  2 in total

Review 1.  Biliary tract infections: a guide to drug treatment.

Authors:  J F Westphal; J M Brogard
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

Review 2.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.